Artrya Limited announced the appointment of Dr Jacob Agris, MD, PhD, as its new Chief Medical Officer effective June 19, 2022. Dr Agris will oversee all medical affairs strategy, clinical development, FDA and global regulatory interactions as well as being a strategic partner and advisor to the CEO and leadership team. With the expansion of Artrya in the US, the appointment of Dr Agris to a full-time role in New York is timely.

As research is key to driving Artrya's innovation, former CMO Professor Girish Dwivedi will now take on the role of Chief Scientific Officer, leveraging his world-renowned research expertise in coronary plaque.